Concepedia

Torben Balchen

TB

10

Publications

295

Citations

10

H-Index

1992

Active since

Affiliations

University of Copenhagen(Current)

Rigshospitalet

Bispebjerg Hospital

Copenhagen University Hospital

Torben Balchen is an author at University of Copenhagen specializing in medicine, neuroprotection, and neurology.

Top concepts

Publications per year

1992–2024

10

Publications

10

A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19

Vibeke Backer, Ulf Sjöbring, Jesper Sonne et al. · The Lancet Regional Health - Europe · 2021 · 67 citations · Full text

Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial

J. Schuhmacher, Sonja Heidu, Torben Balchen et al. · Journal for ImmunoTherapy of Cancer · 2020 · 60 citations · Full text

The AMPA antagonist, NBQX, protects against ischemia-induced loss of cerebellar Purkinje cells

Torben Balchen, Nils Henrik Diemer · Neuroreport · 1992 · 36 citations

, , +22

Changes in mRNA for metabotropic glutamate receptors after transient cerebral ischaemia

D Rosdahl, Dorthe Seitzberg, Thomas Christensen et al. · Neuroreport · 1994 · 27 citations

Tolerability and pharmacokinetics of TB-402 in healthy male volunteers

Peter Verhamme, Steve Pakola, Thomas Jensen et al. · Clinical Therapeutics · 2010 · 24 citations

, , +4

Rows per page

1–5 of 10